Back
Alnylam Pharmaceuticals Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64
ALNY
Alnylam Pharmaceuticals
Last Price:
$324.76
Seasonality Move:
7.34%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Alnylam Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 318.72 | Buy |
20-day SMA: | 319.57 | Buy |
50-day SMA: | 301.46 | Buy |
200-day SMA: | 269.01 | Buy |
8-day EMA: | 318.85 | Buy |
20-day EMA: | 316.7 | Buy |
50-day EMA: | 302.33 | Buy |
200-day EMA: | 268.05 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.84 | Buy |
Relative Strength Index (14 RSI): | 57.23 | Buy |
Chaikin Money Flow: | 1112343 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (308.09 - 325.03) | Buy |
Bollinger Bands (100): | (244.26 - 306.66) | Buy |
Alnylam Pharmaceuticals Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 322.81 while ALNY 8-day simple moving average is 318.72, which is a Buy signal.
-
The stock price of ALNY is 322.81 while Alnylam Pharmaceuticals 20-day SMA is 319.57, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day simple moving average is 301.46 while ALNY share price is 322.81, making it a Buy technically.
-
ALNY stock price is 322.81 and Alnylam Pharmaceuticals 200-day simple moving average is 269.01, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Buy
64
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a BuyThe current Alnylam Pharmaceuticals [ALNY] share price is $322.81. The Score for ALNY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
42.1B
Price in USD:
322.81
Share Volume:
1.2M
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
333.70
52-Week Low:
205.87
Buy
64
Alnylam Pharmaceuticals (ALNY)
is a Buy
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 322.81 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is not overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 322.81 while ALNY 8-day exponential moving average is 318.85, which is a Buy signal.
-
The stock price of ALNY is 322.81 while Alnylam Pharmaceuticals 20-day EMA is 316.70, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 302.33 while ALNY share price is 322.81, making it a Buy technically.
-
ALNY stock price is 322.81 and Alnylam Pharmaceuticals 200-day simple moving average is 268.05, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $1.12 per share, an increase next quarter of $1.55 per share, an increase this year of $1.64 per share, and an increase next year of $3.77 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is 4.84, suggesting Alnylam Pharmaceuticals is a Buy
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 57.23, which suggest Alnylam Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (308.09 - 325.03), which suggest Alnylam Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (244.26 - 306.66), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.